The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist.
Micol RomanoZ Serap AriciDavid PiskinSara AlehashemiDaniel AletahaKaryl BarronSusanne BenselerRoberta A BerardLori BroderickFatma DedeoğluMichelle DieboldKaren DurrantPolly FergusonDirk FoellJonathan S HausmannOlcay Y JonesDaniel KastnerHelen J LachmannRonald M LaxerDorelia RiveraNicolino RupertoAnna SimonMarinka TwiltJoost FrenkelHal M HoffmanAdriana A de JesusJasmin Beate Kuemmerle-DeschnerSeher SenerMarco GattornoRaphaela Goldbach ManskyErkan DemirkayaPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2022)
The 2021 EULAR/American College of Rheumatology points to consider represent state-of-the-art knowledge based on published data and expert opinion to guide diagnostic evaluation, treatment and monitoring of patients with CAPS, TRAPS, MKD and DIRA, and to standardise and improve care, quality of life and disease outcomes.